Edity Therapeutics

Edity Therapeutics is an Israeli biotechnology company developing a platform that harnesses the immune system to deliver therapeutic proteins directly to diseased cells.

Health Tech & Life Sciences
Active
Series A Rehovot, Israel Founded 2019
Last updated 2026-07-26
Total raised
$13.4M
Last: Undisclosed Round 2023-12
Stage
Series A
Founded
2019
Headcount
23
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences

About

Edity Therapeutics is a biotechnology company based in Rehovot, Israel, founded in 2019 (some sources say 2020). The company has developed a proprietary platform that utilizes immune cells to deliver therapeutic proteins directly to the cytoplasm of diseased cells. This technology aims to reprogram cells and tissues back to health by enabling intracellular modulation through mechanisms like protein replacement, target modulation, genetic correction, and protein gain-of-function. Edity is focused on developing therapies for various indications, including oncology and genetic diseases, with programs also in development for regeneration and longevity. The company's approach leverages advanced AI algorithms to engineer therapeutic proteins and optimize them for targeted delivery through the immune system. Edity is particularly focused on addressing challenges in treating solid tumors with cell therapies.

Funding history · 3 rounds · $13.4M total

2023-11
A Round $11.1M
★ Dr. Reddy's Laboratories
2023-09
Seed Extension Undisclosed
★ OurCrowd★ Gaingels★ Loop Ventures★ Reinforced Ventures
2021-08
Seed $2.3M
★ NFX Capital★ Tal Ventures

Headcount over time

From 2 (2020-09) to 23 (2025-12) · +21 (+1050%) · 28 points · source: Finder history + radar grounding
230 2020-09 2025-12

Q&A

What is Edity Therapeutics' primary focus?
Edity Therapeutics is an Israeli biotechnology company developing a platform that harnesses the immune system to deliver therapeutic proteins directly to diseased cells, aiming to reprogram cells and tissues back to health.
When was Edity Therapeutics founded?
Edity Therapeutics was founded in October 2019.
How many employees does Edity Therapeutics currently have?
Edity Therapeutics has 11-50 employees.
What is the total amount of funding Edity Therapeutics has raised to date?
Edity Therapeutics has raised a total of $13,632,300 USD.
When did Edity Therapeutics complete its Series A funding round?
Edity Therapeutics completed its Series A funding round in December 2023, raising $11,100,000 USD.
Did Edity Therapeutics engage in any equity crowdfunding?
Yes, Edity Therapeutics completed an equity crowdfunding round in October 2023, raising $252,300 USD.
What was Edity Therapeutics' first funding round?
Edity Therapeutics' first funding round was a Seed round in September 2021, which raised $2,280,000 USD.
Which company did Edity Therapeutics announce a strategic collaboration with in January 2024?
In January 2024, Edity Therapeutics announced a strategic collaboration with Dr. Reddy's Laboratories to advance a novel cell therapy approach using Edity's proprietary delivery platform.
Who are the founders of Edity Therapeutics?
The founders of Edity Therapeutics are Michal Golan-Mashiach (CEO), Eyal Kolka (Co-Founder and Chairman), and Yoav Manaster (Co-founder).

Team · 3

Michal Golan-Mashiach
Founder · Founder and CEO
Eyal Kolka
Founder · Co-Founder and Chairman
Yoav Manaster
Founder · Co-founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesBiotechnology
Business model
B2B

Highlights

1 Patents

Tags

drug-deliveryproteinsgene-editingbiotechnologygeneticsgenomicsgenetic-disordersoncology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteedity-tx.com
LinkedInlinkedin.com/company/67330457
YouTubeyoutube.com/@editytherapeuticsltd.388

Identifiers & details

Legal nameEdity Therapeutics Ltd.
Founded2019-10
Employees (exact)23

Radar intelligence

Patents

EPO2

Web history (Wayback)

Domainedity-tx.com

Certificate / subdomain footprint

Subdomains1

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516095270
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2019-10-22
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2026
Active charges / liens0
Registry events5 — annual_report (3), violation (1), people (1)
Registered addressפלאוט מנחם 10 רחובות

Recent registry events

DateEvent
2026-06-25דו~ח שנתי-הגדלת הון
2026-06-25דו~ח שנתי-הקצאת מניות
2026-06-25עדכון הפרה
2026-06-25דו~ח שנתי-עדכון כתובת
2026-03-19עדכון בעלי תפקידים